{"id":52579,"date":"2023-01-05T15:02:14","date_gmt":"2023-01-05T14:02:14","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/"},"modified":"2023-01-05T15:02:14","modified_gmt":"2023-01-05T14:02:14","slug":"tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/","title":{"rendered":"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference"},"content":{"rendered":"
\n

HOUSTON–(BUSINESS WIRE)–#IPF<\/a>–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will present at the 41st<\/sup> Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, in San Francisco, CA.\n<\/p>\n

<\/a><\/p>\n

\nPresentation Details:<\/b>\n<\/p>\n

\nDate: Tuesday, January 10, 2023
\n
Time: 5:30 p.m. PST
\n
Location: The Westin St. Francis \u2013 Mission Bay (32nd Floor)\n<\/p>\n

\nAbout Tvardi Therapeutics<\/b>\n<\/p>\n

\nTvardi is a privately held, clinical-stage biopharmaceutical company developing small molecule inhibitors of STAT3, a key regulatory protein positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. STAT3 also plays a central role in the pathogenesis of many inflammatory and fibrotic diseases. The company\u2019s lead product, TTI-101, is completing a first-in-man Phase 1 trial of relapsed\/refractory patients with advanced solid tumors. To date, TTI-101 monotherapy has been well-tolerated and has clinical activity across a broad range of tumors including multiple durable radiographic objective responses. The company has now initiated Phase 2 clinical programs in hepatocellular carcinoma, metastatic breast cancer, and idiopathic pulmonary fibrosis. To learn more, please visit https:\/\/tvarditherapeutics.com\/<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTvardi Investor Relations
\n
Sara Manning
\n
ir@tvardi.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, in San Francisco, CA. Presentation Details: Date: Tuesday, January 10, 2023 Time: 5:30 p.m. PST Location: The … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52579","6":"format-standard","7":"category-industry"},"yoast_head":"\nTvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, in San Francisco, CA. Presentation Details: Date: Tuesday, January 10, 2023 Time: 5:30 p.m. PST Location: The ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-05T14:02:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230105005185\/en\/808014\/21\/Tvardi-Master_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference\",\"datePublished\":\"2023-01-05T14:02:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/\"},\"wordCount\":207,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005185\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/\",\"name\":\"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005185\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\",\"datePublished\":\"2023-01-05T14:02:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005185\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005185\\\/en\\\/808014\\\/21\\\/Tvardi-Master_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Pharma Trend","og_description":"HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (\u201cTvardi\u201d), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, in San Francisco, CA. Presentation Details: Date: Tuesday, January 10, 2023 Time: 5:30 p.m. PST Location: The ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-05T14:02:14+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230105005185\/en\/808014\/21\/Tvardi-Master_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference","datePublished":"2023-01-05T14:02:14+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/"},"wordCount":207,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005185\/en\/808014\/21\/Tvardi-Master_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/","name":"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005185\/en\/808014\/21\/Tvardi-Master_Logo.jpg","datePublished":"2023-01-05T14:02:14+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230105005185\/en\/808014\/21\/Tvardi-Master_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230105005185\/en\/808014\/21\/Tvardi-Master_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/tvardi-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Tvardi Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52579"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52579\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}